Introduction to in vitro diagnostic device regulatory requirements

Area of Science:

• Biomedical Engineering
• Medical Device Technology
• Regulatory Science

Background:

• Microfluidics technology enables precise manipulation of small fluid volumes.
• In Vitro Diagnostics (IVD) devices are crucial for disease detection and monitoring.
• Regulatory compliance is essential for medical device market entry.

Purpose of the Study:

• To outline the regulatory landscape for microfluidic IVD devices in the US and EU.
• To explain the distinct regulatory pathways and requirements in these key markets.
• To provide insights for manufacturers navigating market access for microfluidic diagnostic innovations.

Main Methods:

• Comparative analysis of US Food and Drug Administration (FDA) regulations.
• Examination of European Union (EU) In Vitro Diagnostic Regulation (IVDR) requirements.
• Review of market access strategies for medical devices.

Main Results:

• The US employs a risk-based classification system for IVDs.
• The EU IVDR mandates stringent conformity assessment procedures.
• Significant differences exist in pre-market approval and post-market surveillance between the US and EU.

Conclusions:

• Navigating US and EU regulations requires a thorough understanding of each market's specific requirements.
• Strategic planning is crucial for successful global commercialization of microfluidic IVD devices.
• Harmonization efforts are ongoing but substantial regional differences persist.